Horsetalk.co.nz - Full Article
July 25, 2017
Horsetalk.co.nz
A rider in Saudi Arabia has been suspended for a year and fined 2500 Swiss francs after his mount in a 110km endurance ride last January tested positive for phenylbutazone, oxyphenbutazone, and dexamethasone.
Ibrahim Abdulrahman Alsughayer rode the horse Nashmi Alghzlan in a CEI1* 110km race in Riyadh, Saudi Arabia, on January 14.
The horse was selected for testing, which revealed the presence of the three substances in the blood. Phenylbutazone and dyphenbutazone – a metabolic byproduct of phenylbutazone – are non-steroidal anti-inflammatory drugs with anti-inflammatory and painkilling effects. Dexamethasone is a corticosteroid drug with anti-inflammatory properties...
Read more at http://www.horsetalk.co.nz/2017/07/25/suspension-fine-endurance-horse-drug/#uO7Pb2PBHLwi5Lpd.99
Australia: Keeping it (the Quilty) in the family
NoosaTodeay.com.au - Full Article 25/05/2025 by Erle Levey It was a gallop finish for the coveted Tom Quilty 2025 Gold Cup with Queensla...
-
Inside.fei.org 17 December 2020 The FEI Board took a series of key decisions on allocation, cancellation, and reopening of bids for FEI C...
-
Inside.FEI.org 02 September 2024 Author: Mirjam van Huet A total of 145 athletes and 155 horses are currently preparing for the journe...
-
NoosaToday.com.au - Full Article 06/07/24 Erle Levey The premier event on the Australian endurance horse-riding calendar is to return to...
